Congress of Clinical Rheumatology Annual Meeting

DESTIN, Fla. — At the Clinical Congress of Rheumatology Annual Meeting, Michael R. McClung, MD, discussed current guidelines for treatment of osteoporosis. He spoke about three new drugs that were reviewed to determine their impact on the guidelines.

DESTIN, Fla. — At the Clinical Congress of Rheumatology (CCR) Annual Meeting, Iris Zink, MSN, RN, ANP-BC, spoke about the Latte N’ Learn session and how it empowered women. She said women in the field of Rheumatology and in general need to learn to negotiate for themselves in the workplace.

DESTIN, Fla. — Emerging methods of care could improve the management of difficult-to-treat gout, according to a speaker at the Congress of Clinical Rheumatology Annual Meeting, here.

DESTIN, Fla. — At the Congress of Clinical Rheumatology Annual Meeting, Gary S. Hoffman, MD, MS, MACR, spoke about what rheumatologists need to consider in the treatment of patients with systemic vasculitis.

DESTIN, Fla. – A speaker here at the Congress of Clinical Rheumatology presented data that address the effect of rheumatoid arthritis therapies on cardiovascular and metabolic disease.

DESTIN, Fla. – New drugs and more effective physician-to-patient communication are critical in the treatment of osteoporosis, according to a speaker at the Congress of Clinical Rheumatology.

DESTIN, Fla. – A speaker here at the Congress of Clinical Rheumatology provided an update on Behçet’s syndrome, including a review of its clinical manifestations and new therapy options.

DESTIN, Fla. — Treatment of systemic lupus erythematosus should fluctuate based on the affected organs and severity of the condition, Janet Pope, MD, MPH, professor of medicine, epidemiology and biostatistics at the University of Western Ontario Schulich School of Medicine in London, Ontario, said at the Congress of Clinical Rheumatology Annual Meeting, here.

DESTIN, Fla. — A speaker at the Congress of Clinical Rheumatology Annual Meeting presented new insights in the identification of inflammatory mechanisms for potential therapeutic targets and endpoints in central nervous system lupus and neuropsychiatric systemic lupus erythematosus.

DESTIN, Fla. — There are three overarching principals and 10 recommendations rheumatologists should consider when managing the care of patients with rheumatoid arthritis, according to a speaker at the Congress of Clinical Rheumatology Annual Meeting, here.